Go Pro

Calidi Biotherapeutics (CLDI) Institutional Ownership

Calidi Biotherapeutics logo
$1.36 -0.23 (-14.47%)
As of 04:10 PM Eastern

Institutional Ownership Changes (13F Filings) for Calidi Biotherapeutics (NYSEAMERICAN:CLDI)

Current
Institutional Ownership
Percentage
12.53%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$3.85M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$5.06M
Get CLDI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CLDI Institutional Buying and Selling by Quarter

Calidi Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2026 Virtu Financial LLC21,243$25K0.0%N/A0.296%
2/12/2026 DRW Securities LLC147,767$173K0.0%N/A2.061%
2/9/2026 Geode Capital Management LLC41,929$49K0.0%+41.7%0.585%
11/6/2025 Warberg Asset Management LLC18,705$28K0.0%N/A0.545%
11/3/2025 Belpointe Asset Management LLC41,642$63K0.0%-83.3%1.214%
8/14/2025 Armistice Capital LLC792,000$182K0.0%-76.2%26.173%
8/8/2025 Geode Capital Management LLC232,576$53K0.0%-7.7%7.686%
8/5/2025 Bank of Montreal Can422,500$97K0.0%-13.7%1.163%
5/20/2025Belpointe Asset Management LLC249,833$141K0.0%N/A0.878%
5/15/2025Armistice Capital LLC3,322,000$1.88M0.0%N/A11.669%
5/7/2025Drive Wealth Management LLC55,000$31K0.0%-38.9%0.193%
2/17/2025Millennium Management LLC136,137$157K0.0%+35.5%0.515%
2/14/2025Jane Street Group LLC33,437$38K0.0%N/A0.126%
2/12/2025Geode Capital Management LLC160,018$184K0.0%+304.0%0.605%
2/11/2025Virtu Financial LLC73,448$84K0.0%N/A0.278%
2/10/2025RS Crum Inc.40,463$47K0.0%N/A0.153%
2/7/2025HighTower Advisors LLC102,276$118K0.0%N/A0.386%
2/3/2025Red Wave Investments LLC80,828$93K0.0%+74.0%0.305%
1/22/2025Drive Wealth Management LLC90,000$104K0.0%N/A0.340%
1/14/2025CPR Investments Inc.101,000$116K0.1%+80.4%0.772%
11/15/2024Red Wave Investments LLC46,461$53K0.0%-92.6%0.418%
8/15/2024Delta Investment Management LLC210,230$42K0.0%+1,955.0%0.413%
8/8/2024RS Crum Inc.263,470$53K0.0%+2,327.4%0.517%
7/19/2024CPR Investments Inc.560,000$112K0.1%+700.0%11.002%
5/16/2024Apollo Management Holdings L.P.125,000$71K0.0%N/A0.352%
5/15/2024Magnetar Financial LLC63,132$36K0.0%N/A0.178%
5/14/2024Evermay Wealth Management LLC63,416$36K0.0%N/A0.178%
4/23/2024Spectrum Asset Management Inc. NB CA 166,494$94K0.0%N/A0.468%


CLDI Institutional Ownership - Frequently Asked Questions

During the previous two years, 14 institutional investors and hedge funds held shares of Calidi Biotherapeutics. The most heavily invested institutionals were Armistice Capital LLC ($182K), DRW Securities LLC ($173K), Millennium Management LLC ($157K), HighTower Advisors LLC ($118K), CPR Investments Inc. ($116K), Bank of Montreal Can ($97K), and Red Wave Investments LLC ($93K).Learn more on Calidi Biotherapeutics' institutional investors.

12.53% of Calidi Biotherapeutics' stock is owned by institutional investors. Learn more on CLDI's institutional investor holdings.

Of the 13 institutional investors that purchased Calidi Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($3.32M), Belpointe Asset Management LLC ($249.83K), DRW Securities LLC ($147.77K), Geode Capital Management LLC ($132.74K), HighTower Advisors LLC ($102.28K), Virtu Financial LLC ($94.69K), and Drive Wealth Management LLC ($90K).

Institutional investors have bought a total of 200,049 shares in the last 24 months. This purchase volume represents approximately $3.85M in transactions.

The following institutional investors have sold Calidi Biotherapeutics stock in the last 24 months: Belpointe Asset Management LLC ($208.19K).

Institutional investors have sold a total of 208,191 shares in the last 24 months. This volume of shares sold represents approximately $5.06M in transactions.



Institutional ownership data for NYSEAMERICAN:CLDI is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 2/23/2026. New 13F filings are added each quarter as they're published.
From Our Partners